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Edited by Ivan SadowskiAbstract We conducted a phenotypic cDNA screening using a
T cell line-based assay to identify human genes that render cells
resistant to human immunodeﬁciency virus type 1 (HIV-1). We
isolated potential HIV-1 resistance genes, including the carboxy
terminal domain (CTD) of bromodomain-containing protein 4
(Brd4). Expression of GFP-Brd4-CTD was tolerated in MT-4
and Jurkat cells in which HIV-1 replication was markedly inhib-
ited. We provide direct experimental data demonstrating that
Brd4-CTD serves as a speciﬁc inhibitor of HIV-1 replication
in T cells. Our method is a powerful tool for the identiﬁcation
of host factors that regulate HIV-1 replication in T cells.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The identiﬁcation of speciﬁc molecular interactions required
for eﬃcient HIV-1 replication should provide clues towards
improved understanding of the mechanisms of viral pathogen-
esis, as well as of host defence against HIV-1. In addition, this
may help design highly speciﬁc inhibitors against HIV-1. Gen-
ome-wide screening for HIV-1 replication regulatory factors
has been attempted by using various experimental approaches.
Most of them were based on adherent epithelial cells, because
these cells exhibit higher transduction eﬃciencies (by transfec-
tion or by viral vector transfer) when compared with T cell
lines [1,2]; however, cells of epithelial origin are not relevant
hosts for HIV-1 in vivo. Furthermore, viral vectors pseudo-
typed with vesicular stomatitis virus-G (VSV-G) are often used
for screening purposes, instead of wild-type HIV-1. These
vectors enter cells via the VSV-G-restricted route, which is*Corresponding author. Fax: +81 3 5285 5037.
E-mail address: ajkomano@nih.go.jp (J. Komano).
0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2008.10.047diﬀerent from the HIV-1 envelope-mediated entry pathway.
These factors constitute potential caveats of these assays.
To overcome these potential problems, we carried out a phe-
notypic screen to identify human cDNAs that confer resistance
to HIV-1 replication, without aﬀecting cell proliferation. The
assay was performed in a human T cell line, a physiologically
relevant host, stably transduced with a human cDNA library.
We isolated several potential HIV-1 resistance genes success-
fully, many of which were not known as HIV-1 regulatory fac-
tors. In this work, we studied Brd4 in detail to demonstrate the
applicability of our phenotype screening. Our study of Brd4-
CTD suggests the presence of a potential anti-HIV-1 drug tar-
get in the host transcription regulator cyclin T1 (CCNT1).2. Materials and methods
2.1. Cells and transfection
Cells were maintained in RPMI 1640 medium (Sigma, St. Louis,
MA) supplemented with 10% fetal bovine serum (Japan Bioserum, To-
kyo), 50 U/ml penicillin, and 50 lg/ml streptomycin (Invitrogen, To-
kyo, Japan), and then incubated at 37 C in a humidiﬁed 5% CO2
atmosphere. Cells were transfected with Lipofectamine 2000 according
to the manufacturers protocol (Invitrogen).
2.2. Plasmid construction
The Brd4-CTD was ampliﬁed from 293T RNA by reverse transcrip-
tase PCR (RT-PCR) using the primers 5 0-AGATCTCTCATCC-
GACCACCCCCTCCTCC-30 and 5 0-TCAGGATCCCGAAAAGA
TTTTCTTCAAATATTG-3 0. The BglII–BamHI fragment of the
PCR product was cloned into the corresponding restriction sites of
the pEGFP-C2 (Clontech, Palo Alto, CA). The XhoI–MfeI fragment
from the resulting plasmid was cloned into the corresponding restric-
tion sites of the pCMMP KRAB vector, creating the pGFP-Brd4-
CTD. The cDNA encoding ﬁreﬂy luciferase (Luc+) was ampliﬁed by
PCR from the pGL3-Basic (Promega, Madison, WI) using the primers
5 0-ACCGGTCTCGAGGGCCACCATGGAAGACGCCAAAAACA-
TAAAGAAAGG-3 0 and 5 0-GAATTCGGATCCTTACACGGC-
GATCTTTCCGCCCTTCTTGGCC-30. The PCR product was
digested with AgeI and BamHI, and cloned into the corresponding
sites of the pCMMP GFP vector, generating the pCMMP Luciferase.
The BamHI–XhoI fragment of pLenti6/V5-GW/lacZ (Invitrogen) was
removed, and Luc+ was inserted with BglII and SalI sites artiﬁcially at-
tached at its extremities, creating the pLenti Luciferase. Other plasmids
used in this study were described previously [3,4].blished by Elsevier B.V. All rights reserved.
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The lentiviral vector carrying an hPBL cDNA library was described
previously [5]. MT-4 cells (1 · 106) transduced with the cDNA library
were infected with HIV-1HXB2 propagated in MT-2 cells, by resuspend-
ing MT-4 cells in a viral preparation containing 70–1250 ng/ml p24 vir-
al capsid antigen in 20 ml of culture medium for 30 min at room
temperature with continuous mixing. Anti-CD4 magnetic beads (0.5–
1.0 · 107; Dynal, Oslo, Norway) were added to the cell suspension to
prevent cell-to-cell contact, and the cells (1 · 103 cells per well in
200 ll of culture medium) were plated in ﬂat-bottomed 96-well plates.
At 3–4 weeks post-infection, cells from four wells positive for cell out-
growth were pooled and genomic DNA was extracted. The cDNA in-
serts were PCR-ampliﬁed and sequenced using primers described
previously [5].
2.4. Generation of viruses and infection
Viruses were produced as described previously [3,4]. Human T cell
lines (MT-4 and Jurkat cells; 1 · 105 cells) were incubated with 500–
1000 ll of MLV preparations in the presence of 8 lg/ml polybrene
for 1 h at 4 C with continuous agitation. For HIV-1 infection,
1 · 105 cells were incubated with an HIV-1-containing culture superna-
tant (ca. 5–5000 pg p24), for 30 min at room temperature. HIV-1 rep-
lication was monitored as described previously [3,4].
2.5. Western blotting
Western blotting was performed according to techniques described
previously [4]. The following antibodies were used: anti-CCNT1
(ab2098, Abcam, MA), anti-Brd4 (ab46199, Abcam), anti-GFP
(MAB3580, Chemicon International, Temecula, CA or 632381, Clon-
tech), anti-p24 (183-H12-5C, NIH AIDS Research and Reference Re-
agent Program), anti-HEXIM1 (ab25388, Abcam), anti-Bip/GRP78
(clone 40, BD Transduction Laboratories), and EnVision+ system
(Dako, Glostrup, Denmark).
2.6. Reporter assay
The 293T cells grown in 48-well plates were co-transfected with
20 ng of pLTR-Luc or pCMMP Luciferase, together with pGFP-
Brd4-CTD. The total amount of transfected DNA was adjusted by
pCMMP GFP. To measure the eﬀect of Tat, cells were co-transfected
with 100 ng of pSVtat in addition to the above-mentioned plasmids.
Cells were replated in 96-well plates in triplicate at 2–4 h post-transfec-
tion. Luciferase activity was measured 48 h after transfection using the
Dual-Glo assay kit (Promega).Table 1
Summary of cDNAs recovered in an HIV-1-resistant phenotype screening in
Gene category # of independent clones Frequency (%)
Metabolism 16 24.6
Transcription 7 10.8
Ribosomal proteins 7 10.8
Signal transduction 7 10.8
Traﬃcking 6 9.2
Immunology 2 3.1
Oncogenesis 2 3.1
Glycosylation 2 3.1
Diﬀerentiation 2 3.1
Cytoskeleton 2 3.1
Cell cycle control 1 1.5
Apoptosis 1 1.5
DNA repair 1 1.5
Non-ORF coding 9 13.8
Total 65 100.0
aAll the clones isolated more than three times are listed. A representative cl
bThese genes exhibited regulatory functions on HIV-1 production.
cThese genes exhibited no eﬀect on HIV-1 production.2.7. RT-PCR
RT-PCR was performed as described previously [4]. For ampliﬁca-
tion of HIV-1 mRNA, forward (5 0-CTCGACGCAGGACTCGGCT-
TGC-3 0) and reverse (5 0-AGTTCCACTCCTGCCCAAGTATCC-3)
primers were used. The mRNA encoding glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was ampliﬁed using the primers 5 0-GTG-
GAAGGACTCATGACCACAGTC-3 0 and 5 0- CATGTGGGCCA-
TGAGGTCCACCAC-3 0.
2.8. Quantitative real-time PCR
The real-time PCR reaction was performed as described previously
[4]. Ampliﬁcations were performed using the QuantiTect SYBR Green
RT-PCR/PCR Kit (QIAGEN). To estimate the amount of integrated
HIV-1 DNA, Alu-LTR PCR was performed as described previously
[6] using the following primers: ﬁrst PCR reaction, 5 0-AACTAGGGA-
ACCCACTGCTTAAG-3 0 and 5 0-TGCTGGGATTACAGGCGT-
GAG-3 0; and second PCR reaction, 5 0-AACTAGGGAACCCA-
CTGCTTAAG-3 0 and 5 0-CTGCTAGAGATTTTCCACACTGAC-3 0.3. Results
To isolate cDNA clones that confer resistance to HIV-1
without negatively aﬀecting cell proliferation, we performed
phenotype screening using MT-4 cells stably transduced with
a lentiviral vector carrying a cDNA library from human
peripheral blood lymphocytes (hPBL). The complexity of the
lentiviral cDNA library was on the order of 106. The lentiviral
vector encoded a GFP expression cassette. Approximately 70%
of the MT-4 cells became GFP-positive after infection of the
lentiviral vector, suggesting that a portion of the cells were in-
fected with multiple lentiviral vectors. The GFP-positive cells
were collected using a FACS sorter and subsequently exposed
to replication-competent HIV-1. The surviving cell clones were
propagated and their transduced cDNAs were examined. The
average length of hPBL cDNA in the lentiviral vector was
0.7 kbp, which is shorter than the average human cellular
mRNA length (2 kbp). A gene was considered an innateMT-4 cells.
Frequently isolated genesa (# of independent clones)
Haemoglobin (7)
Pyridoxal kinase, PDXK (3)
Bromodomain containing 4, Brd4 (3)
Zinc ﬁnger protein 26, ZNF26 (3)
Ribosomal protein L14, RPL14 (3)
Zinc ﬁnger protein 36, ZFP36L2 (2) transducin
beta-like 1X-linked, TBL1X (1)c
Chromosome 22 open reading frame 5, C22orf5 (1)c
Chromosome 9 open reading frame 86, C9orf86 (1)b
Chromosome 1 open reading frame 142, C1orf142 (1)b
Nedd4-binding partner 3, N4BP3 (1)
MHC class II, DR alpha (1)
AXIN1 up-regulated, AXUD1 (1)c
Hyaluronan and proteoglycan link protein 3, HAPLN3 (1)
Jumonji AT rich interactive domain 2, JARID2 (1)
Beta actin (1)
CWF19-like 1, CWF19L1 (1)
Chromosome 2 open reading frame 28, C2orf28 (1)
Non-SMC element 1 homolog, NSMCE1 (1)b
–
–
one is shown for categories with a few candidates.
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reading frame (ORF) was recovered. Alternatively, if a portion
of a gene was recovered, the full-length gene was considered a
potential positive factor for HIV-1 replication. We recovered
65 independent cDNA clones (43 genes, Table 1). A number
of cDNAs encoded abundant cellular transcripts, including
haemoglobin. In addition, cDNAs encompassing non-ORFs
were isolated. The isolation of these cDNAs was likely due
to the infection of a single cell with multiple cDNA-transduc-
ing lentiviral vectors, one of which encoded an HIV-1 resis-
tance gene. If we disregard these cases, 26 genes were
potential HIV-1 regulatory gene candidates, of which seven
were examined for a potential HIV-1 regulatory functions as
shown inFig. 2. Four genes exhibited HIV-1 regulatory pheno-
types (4/7 genes, 57.1%; Table 1). In addition to Brd4-CTD,
C9orf86 and NSMCE1 scored as positive factors for HIV-1
replication, and C1orf142 was scored as a negative factor. This
suggested that our screening was successful in selecting for
HIV-1 regulatory genes. While each candidate gene will be
studied in detail in future studies, here we focused on Brd4.
Brd4 was chosen for three reasons: (1) three independent
Brd4 cDNAs were recovered; (2) Brd4 binds to the CCNT1/
T2-bearing P-TEFb complex [7,8]; and (3) 13 independent
Brd4 cDNA clones (13/42 clones, 31.0%) were isolated fromFig. 1. Speciﬁc inhibition of Tat-dependent LTR transcription by GFP-Brd4-
cDNAs. (B) Construction of MLV vector-based mammalian expression pl
images of MT-4 cells stably expressing GFP or GFP-Brd4-CTD. Green and b
Magniﬁcation, 630·; scale bar, 5 lm. (D) Eﬀect of GFP-Brd4-CTD on LTR
expression plasmid. Cells transfected with 0, 16, 80, and 400 ng of pGFP-B
respectively. Representative data from ﬁve independent experiments are shoa similar experiment in which the cDNA library from an Oryc-
tolagus cuniculus kidney derived cell line was used. All the three
Brd4 cDNA clones encoded Brd4-CTD: two encoded amino
acids (aa) 1260–1362 and the third encoded aa 1209–1362
(Fig. 1A). The ﬁrst two clones were translated using the
Met-encoding codon at Brd4 nucleotide position 3778–3780,
and the third was translated from the aberrant start codon
in the primer upstream of the Brd4 ORF 3628 nt. To our sur-
prise, aa fragment 1209–1264 of Brd4 was recently reported as
an interactor of CCNT1 that inhibits Tat-dependent LTR-dri-
ven transcription [9]; however, the speciﬁc eﬀect of this region
on HIV-1 replication in human T cells was not fully investi-
gated.
We hypothesized that the repression of HIV-1 replication in
MT-4 cells may be due to the selective inhibition of viral gene
transcription by Brd4-CTD. To test this, we cloned Brd4-CTD
spanning aa 1209-1364 into a retroviral plasmid and fused
GFP to its carboxy-terminus (GFP-Brd4-CTD, Fig. 1B). Con-
focal microscopy revealed that GFP-Brd4-CTD was localized
mainly in the cytoplasm of MT-4 cells, with some signal found
in the nucleus (Fig. 1C). A transient transfection assay
revealed that the expression of GFP-Brd4-CTD modestly
enhanced the luciferase expression driven by both the LTR
and CMV promoters (Fig. 1D). In the presence of Tat, LTRCTD. (A) Functional properties of the Brd4 domains and isolated Brd4
asmids encoding GFP or GFP-Brd4-CTD. (C) Confocal microscopy
lue represent GFP and the Hoechst 33258-stained nuclei, respectively.
and CMV promoter activities in the absence or presence of the Tat
rd4-CTD correspond to black, dark gray, light gray, and white bars,
wn.
Fig. 2. Inhibition of HIV-1 production by GFP-Brd4-CTD. (A) Viral production was quantiﬁed by ELISA detecting p24 viral antigen. The relative
decrease in viral levels are indicated on the top of the graph. (B) The viral protein levels in transfected cells were analyzed by Western blotting using
the antibodies indicated. (C) The viral spliced transcript and GAPDH mRNA were ampliﬁed by RT-PCR. Lanes 1–4 in B and C correspond to the
amount of pGFP-Brd4-CTD (0, 16, 80, and 400 ng, respectively). Quantiﬁcation of these data is summarized in Table 2.
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expression vector was co-transfected, the Tat-dependent
enhancement of LTR promoter-driven luciferase expression
decreased. A similar trend was not observed for the CMV pro-
moter. These data suggest that the Brd4-CTD speciﬁcally lim-
its Tat-dependent LTR transcription.
We also investigated the eﬀect of GFP-Brd4-CTD expres-
sion on HIV-1 production by using a proviral DNA mimicking
the late phase of the viral life cycle. Consistent with the results
described above, transfection of HIV-1 proviral DNA together
with an increasing amount of the GFP-Brd4-CTD expression
vector led to a decrease of viral yield, as well as of the levels
of viral protein and mRNA in the transfected cells (Fig. 2).
The viral RNA levels dropped in parallel with the protein lev-
els, as demonstrated by real-time RT-PCR analysis (Fig. 2C
and Table 2). These data suggest that GFP-Brd4-CTD inhibits
HIV-1 production by blocking viral transcription.
To conﬁrm the blockage of HIV-1 replication by Brd4-CTD,
GFP-Brd4-CTD was transduced into MT-4 and Jurkat cells
using an MLV-based vector (Fig. 3A). Green ﬂuorescence indi-
cated that the eﬃciency of MLV-mediated gene transduction
in MT-4 cells was >90%, with a lower transduction eﬃciency
observed in Jurkat cells, as estimated by FACS analysis. The
GFP-positive Jurkat cells were collected using a FACS sorter.
The expression of GFP and GFP-Brd4-CTD was veriﬁed by
Western blot analysis (Fig. 3B). The expression levels of tran-
scription-related gene products were not detectably aﬀected by
the constitutive expression of GFP-Brd4-CTD (Fig. 3B). InTable 2
Eﬀect of GFP-Brd4-CTD on viral production examined by quantitative rea
pGFP-Brd4-CTD (ng) HIV-1 mRNA (copy)a GAPDH mRNA (copy)a
0 274250 261750
16 221600 228850
80 138050 311450
400 120850 347750
aCopy per 100 ng total cellular RNA.
bRelative reduction of HIV-1 mRNA considering pGFP-Brd4-CTD 0 ng as
cSee Fig. 2.addition, there was no detectable diﬀerence in the levels of
cell-surface HIV-1 receptors (CD4 and CXCR4), cell morphol-
ogy, and cell proliferation rates between GFP- and GFP-Brd4-
CTD-expressing cells (Fig. 1C and Supplementary data). We
found that HIV-1 replicated less eﬃciently in GFP-Brd4-
CTD-expressing cells than in GFP-expressing cells, in both cell
lines tested, which conﬁrms the HIV-1-resistant phenotype of
MT-4 cells (Fig. 3C). The eﬃciency of viral genome integration
into GFP-Brd4-CTD-expressing cells was indistinguishable
from that of GFP-expressing cells (103.2 ± 24.1%) as examined
by Alu-LTR PCR, suggesting that the early phase of the viral
life cycle was not blocked by GFP-Brd4-CTD.4. Discussion
Our phenotype screening method proved to be a powerful
tool because a human T cell line was subjected to HIV-1 resis-
tance screening by stable and non-transient introduction of a
human cDNA library, and because wild-type HIV-1 was used;
thus, the eﬀect of candidate gene expression on cell prolifera-
tion was less of a concern in this system when compared with
transient assay systems. In addition, HIV-1 inhibitory genes
were isolated at a frequency of 15% (4/26 genes), 75% of
which were novel. We therefore believe that our system is
remarkable in selecting genes that confer HIV-1 resistance in
T cells. By applying this assay to other cDNA libraries, wel time RT-PCR and ELISA.
Ratio (HIV-1/GAPDH) Normalized (%)b p24 ELISA (%)c
1.048 100.0 100.0
0.968 92.4 95.2
0.443 42.3 60.7
0.348 33.2 23.5
100%.
Fig. 3. Constitutive expression of GFP-Brd4-CTD limited the replication of HIV-1. (A) Experimental design. MT-4 and Jurkat cells were transduced
with an MLV vector expressing GFP-Brd4-CTD. Cells were challenged by HIV-1 and the eﬃciency of viral replication was examined. (B) Western
blot analysis of the expression levels of GFP, GFP-Brd4-CTD, Brd4 (arrowhead), CCNT1, CDK9, HEXIM1, and BiP in established MT-4 and
Jurkat cells. (C) HIV-1 replication kinetics in MT-4 and Jurkat cells constitutively expressing GFP (black circles) or GFP-Brd4-CTD (white circles).
Representative data from two independent experiments are shown.
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1 replication.
The assessment of the selective impact of altered candidate
gene expression or function on HIV-1 replication (without
the alteration of cell proliferation) is critical to the identiﬁca-
tion of cellular molecular targets for novel anti-retroviral
drugs. We demonstrated that Brd4-CTD was a speciﬁc silencer
of HIV-1 replication, and veriﬁed that it eﬀectively blocked
HIV-1 replication in multiple human T cell lines without aﬀect-
ing cell proliferation. Our data indicate that primate lentiviral
replication is more heavily dependent on the CCNT1-contain-
ing P-TEFb complex than cellular gene transcription, which is
consistent with previous ﬁndings [4,10–11]. This implies that
HIV-1 replication can be controlled by selectively restricting
the CCNT1-containing P-TEFb complex. Our transcription
assay indicated that the Brd4-CTD is not an inhibitor of the
P-TEFb complex, but is rather a functional Tat inhibitor. Pre-
vious biochemical studies have suggested that Brd4-CTD andTat bind to CCNT1 in a reciprocally exclusive fashion [7,9].
Given that the binding regions of these two proteins do not
overlap, Brd4-CTD may be an allosteric inhibitor of the Tat-
CCNT1 interaction. Taken together, our results indicate that
the Brd4-interacting region of CCNT1 is a potential molecular
target for the development of a novel HIV-1 inhibitor.
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